Clinical Trial Update: Comparison of Treatment Response to Intravitreal Injection of Combined Propranolol and Bevacizumab Versus Bevacizumab Monotherapy in Patients With Wet Age Related Macular Degeneration :A Clinical Trial [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial is investigating whether combining propranolol with bevacizumab for intravitreal injection improves treatment response in wet age-related macu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Bevacizumab (bevacizumab)
• Propranolol (propranolol)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Age Related Macular Degeneration | Phase 2, Phase 3 | Status: UNKNOWN